STRS Ohio’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,100
| Closed | -$7K | – | 2171 |
|
|
2023
Q1 | $7K | Hold |
4,100
| – | – | ﹤0.01% | 1912 |
|
|
2022
Q4 | $4K | Hold |
4,100
| – | – | ﹤0.01% | 1961 |
|
|
2022
Q3 | $9K | Hold |
4,100
| – | – | ﹤0.01% | 1975 |
|
|
2022
Q2 | $12K | Hold |
4,100
| – | – | ﹤0.01% | 1990 |
|
|
2022
Q1 | $27K | Hold |
4,100
| – | – | ﹤0.01% | 2022 |
|
|
2021
Q4 | $34K | Hold |
4,100
| – | – | ﹤0.01% | 2059 |
|
|
2021
Q3 | $30K | Sell |
4,100
-8,100
| -66% | -$50.2K | ﹤0.01% | 2142 |
|
|
2021
Q2 | $82K | Hold |
12,200
| – | – | ﹤0.01% | 2020 |
|
|
2021
Q1 | $125K | Sell |
12,200
-17,400
| -59% | -$191K | ﹤0.01% | 1904 |
|
|
2020
Q4 | $207K | Sell |
29,600
-18,800
| -39% | -$146K | ﹤0.01% | 1733 |
|
|
2020
Q3 | $394K | Sell |
48,400
-22,700
| -32% | -$141K | ﹤0.01% | 1452 |
|
|
2020
Q2 | $490K | Sell |
71,100
-34,500
| -33% | -$186K | ﹤0.01% | 1321 |
|
|
2020
Q1 | $501K | Buy |
105,600
+37,600
| +55% | +$216K | ﹤0.01% | 1127 |
|
|
2019
Q4 | $593K | Sell |
68,000
-86,800
| -56% | -$469K | ﹤0.01% | 1350 |
|
|
2019
Q3 | $515K | Buy |
154,800
+59,700
| +63% | +$239K | ﹤0.01% | 1260 |
|
|
2019
Q2 | $470K | Buy |
+95,100
| New | +$505K | ﹤0.01% | 1340 |
|
|
2018
Q2 | – | Sell |
-19,500
| Closed | -$435K | – | 2206 |
|
|
2018
Q1 | $435K | Sell |
19,500
-8,200
| -30% | -$182K | ﹤0.01% | 1361 |
|
|
2017
Q4 | $353K | Sell |
27,700
-13,600
| -33% | -$200K | ﹤0.01% | 1399 |
|
|
2017
Q3 | $643K | Buy |
41,300
+4,000
| +11% | +$56.6K | ﹤0.01% | 1242 |
|
|
2017
Q2 | $523K | Buy |
37,300
+35,400
| +1,863% | +$758K | ﹤0.01% | 1327 |
|
|
2017
Q1 | $41K | Buy |
+1,900
| New | +$40.3K | ﹤0.01% | 1796 |
|
Other funds holding JNCE
STRS Ohio's JNCE Position: Q2 2023 in Review
STRS Ohio sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 4,100 shares — an estimated $7K sold.
STRS Ohio first reported a position in JNCE in Q1 2017 and held it in 21 quarters. The position peaked at $643K in Q3 2017. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.
- STRS Ohio reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- STRS Ohio sold 4,100 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $7K.
- STRS Ohio first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2017 and held it in 21 quarters.
- STRS Ohio's Jounce Therapeutics, Inc. Common Stock position peaked at $643K in Q3 2017.
- 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.
Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.